KIYATEC Inc

Kiyatec Inc. is a privately held company located in Greenville, South Carolina. Employing 22 individuals, Kiyatec generates approximately $4 million in annual revenue. Kiyatec focuses on revolutionizing cancer care by predicting, with precision, how individual patients will respond to various cancer therapies. Utilizing a patient's own tumor cells, they construct functional 3D models within their CLIA-certified laboratories. These models are then subjected to a comprehensive battery of cancer therapies, allowing physicians to identify the most effective treatments for each patient. Kiyatec's innovative approach has garnered recognition from prominent cancer hospitals, numerous top 10 pharmaceutical companies, and the National Cancer Institute (NCI). The company actively conducts clinical trials to solidify the efficacy of their methodology and pave the way for widespread adoption of their diverse product portfolio, encompassing predictions for responses to current and future cancer therapies. For further information, please visit Kiyatec's website at www.kiyatec.com.